CD38-directed Cytolytic Antibody [EPC]

CD38-directed Cytolytic Antibody [EPC] was reported 5853 times

Drugs of the CD38-directed Cytolytic Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CROSSMATCH INCOMPATIBLE 45 0.7031
1 COOMBS INDIRECT TEST POSITIVE 39 0.5270
2 BLOOD STEM CELL HARVEST 16 0.4324
3 PLASMA CELL MYELOMA REFRACTORY 573 0.4283
4 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 25 0.2809
5 PSEUDOMYOPIA 29 0.2500
6 PLASMA CELL LEUKAEMIA 128 0.2133
7 LIGHT CHAIN DISEASE 30 0.2069
8 PRIMARY AMYLOIDOSIS 48 0.1868
9 MONOCLONAL IMMUNOGLOBULIN INCREASED 50 0.1748
10 NATURAL KILLER CELL COUNT DECREASED 16 0.1739
11 IVTH NERVE PARALYSIS 39 0.1646
12 METAPNEUMOVIRUS PNEUMONIA 15 0.1562
13 LIGHT CHAIN ANALYSIS ABNORMAL 31 0.1490
14 ACUTE MYOPIA 26 0.1429
15 BLOOD STEM CELL HARVEST FAILURE 21 0.1419
16 LIGHT CHAIN ANALYSIS INCREASED 146 0.1413
17 PLASMACYTOMA 260 0.1396
18 ASPIRATION BONE MARROW 18 0.1353
19 ADMINISTRATION RELATED REACTION 25 0.1282
20 PLASMA CELL MYELOMA RECURRENT 371 0.1141
21 PLASMA CELL MYELOMA 4384 0.1123
22 MONOCLONAL IMMUNOGLOBULIN PRESENT 71 0.0934
23 MENINGITIS LISTERIA 47 0.0922
24 PNEUMONIA PARAINFLUENZAE VIRAL 15 0.0882
25 STEM CELL TRANSPLANT 215 0.0860
26 LISTERIA SEPSIS 20 0.0758
27 PARAPROTEINAEMIA 21 0.0677
28 PLASMABLASTIC LYMPHOMA 23 0.0642
29 OSTEOLYSIS 129 0.0630
30 MORGANELLA INFECTION 18 0.0614
31 HYPOGAMMAGLOBULINAEMIA 398 0.0605
32 BLOOD IMMUNOGLOBULIN A DECREASED 39 0.0599
33 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 50 0.0593
34 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 21 0.0579
35 CARDIAC AMYLOIDOSIS 58 0.0527
36 TRANSPLANT 122 0.0513
37 BODY DYSMORPHIC DISORDER 19 0.0507
38 PNEUMOCOCCAL SEPSIS 33 0.0502
39 PARAINFLUENZAE VIRUS INFECTION 75 0.0492
40 MONOCLONAL GAMMOPATHY 30 0.0478
41 PNEUMONIA HAEMOPHILUS 23 0.0473
42 VISCERAL LEISHMANIASIS 34 0.0471
43 CYTOMEGALOVIRUS INFECTION REACTIVATION 205 0.0464
44 INFUSION RELATED REACTION 3006 0.0453
45 COOMBS DIRECT TEST POSITIVE 14 0.0449
46 POLYNEUROPATHY 536 0.0447
47 BONE MARROW TRANSPLANT 83 0.0437
48 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 35 0.0431
49 MINIMAL RESIDUAL DISEASE 20 0.0414
50 PNEUMONIA PNEUMOCOCCAL 60 0.0405
51 PNEUMONIA INFLUENZAL 48 0.0403
52 FEBRILE INFECTION 47 0.0399
53 BLOOD IMMUNOGLOBULIN A INCREASED 21 0.0390
54 CYTOPENIA 452 0.0369
55 BONE LESION 122 0.0338
56 COVID-19 PNEUMONIA 399 0.0338
57 CEREBRAL TOXOPLASMOSIS 31 0.0332
58 AMYLOIDOSIS 57 0.0330
59 BLOOD IMMUNOGLOBULIN M DECREASED 33 0.0329
60 LISTERIOSIS 34 0.0307
61 IMMUNOGLOBULINS DECREASED 41 0.0298
62 TUMOUR LYSIS SYNDROME 256 0.0291
63 GASTROENTERITIS SALMONELLA 24 0.0288
64 HERPES ZOSTER DISSEMINATED 23 0.0286
65 HUMAN POLYOMAVIRUS INFECTION 15 0.0282
66 BLOOD IMMUNOGLOBULIN G DECREASED 69 0.0278
67 LABORATORY TEST INTERFERENCE 21 0.0267
68 IGA NEPHROPATHY 44 0.0265
69 INTERVERTEBRAL DISCITIS 50 0.0265
70 JOINT ANKYLOSIS 15 0.0264
71 CYTOMEGALOVIRUS CHORIORETINITIS 51 0.0261
72 MEASLES 14 0.0260
73 H1N1 INFLUENZA 35 0.0249
74 CYTOMEGALOVIRUS ENTEROCOLITIS 19 0.0247
75 PERIPHERAL SENSORIMOTOR NEUROPATHY 31 0.0247
76 JC VIRUS INFECTION 38 0.0238
77 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 14 0.0237
78 PNEUMONIA CYTOMEGALOVIRAL 46 0.0237
79 HAEMOPHILUS INFECTION 23 0.0234
80 INJECTION RELATED REACTION 38 0.0230
81 PULMONARY SEPSIS 33 0.0227
82 GRANULOCYTE COUNT DECREASED 42 0.0226
83 PERIPHERAL SENSORY NEUROPATHY 131 0.0224
84 RENAL VEIN THROMBOSIS 15 0.0222
85 RESPIRATORY TRACT INFECTION VIRAL 51 0.0219
86 NASAL OBSTRUCTION 41 0.0218
87 ENDOCARDITIS BACTERIAL 17 0.0216
88 LYMPHOPENIA 304 0.0215
89 SECONDARY IMMUNODEFICIENCY 26 0.0214
90 ESCHERICHIA SEPSIS 62 0.0214
91 CHOROIDAL EFFUSION 17 0.0212
92 THERAPY PARTIAL RESPONDER 327 0.0209
93 HEPATITIS E 33 0.0209
94 STEROID DIABETES 31 0.0207
95 METAPNEUMOVIRUS INFECTION 16 0.0204
96 OCULAR TOXICITY 22 0.0199
97 PATHOLOGICAL FRACTURE 101 0.0199
98 AUTONOMIC NEUROPATHY 20 0.0197
99 NEUTROPENIA 2672 0.0196
100 BACTERIAL SEPSIS 63 0.0193
101 DEVICE RELATED THROMBOSIS 19 0.0193
102 BK VIRUS INFECTION 65 0.0193
103 CYTOKINE RELEASE SYNDROME 382 0.0190
104 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 25 0.0190
105 CEREBRAL VENOUS SINUS THROMBOSIS 16 0.0189
106 HYPERPYREXIA 80 0.0189
107 MYELOSUPPRESSION 675 0.0187
108 ESCHERICHIA BACTERAEMIA 44 0.0187
109 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 14 0.0183
110 ABDOMINAL SEPSIS 16 0.0182
111 TROPONIN T INCREASED 23 0.0181
112 PNEUMONIA LEGIONELLA 29 0.0181
113 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 25 0.0178
114 HAEMATOTOXICITY 168 0.0177
115 NEUROPATHY PERIPHERAL 1670 0.0175
116 FEBRILE BONE MARROW APLASIA 74 0.0174
117 DEVICE RELATED SEPSIS 35 0.0174
118 MASTOIDITIS 17 0.0173
119 INFECTIOUS PLEURAL EFFUSION 26 0.0171
120 CYTOMEGALOVIRUS VIRAEMIA 76 0.0171
121 CYTOMEGALOVIRUS TEST POSITIVE 30 0.0168
122 DILATED CARDIOMYOPATHY 17 0.0168
123 VARICELLA 40 0.0167
124 THROMBOTIC MICROANGIOPATHY 162 0.0166
125 INFECTION REACTIVATION 19 0.0166
126 HUMAN CHORIONIC GONADOTROPIN INCREASED 15 0.0166
127 ACINETOBACTER INFECTION 18 0.0164
128 NEUTROPHIL COUNT DECREASED 655 0.0161
129 DIVERTICULAR PERFORATION 33 0.0160
130 THROMBOCYTOPENIA 1791 0.0160
131 CYTOMEGALOVIRUS INFECTION 265 0.0159
132 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 131 0.0159
133 KERATOPATHY 25 0.0158
134 HYPERCALCAEMIA 191 0.0155
135 PNEUMOCYSTIS JIROVECII PNEUMONIA 154 0.0153
136 INTRADUCTAL PROLIFERATIVE BREAST LESION 19 0.0152
137 SQUAMOUS CELL CARCINOMA OF SKIN 91 0.0151
138 FEBRILE NEUTROPENIA 989 0.0149
139 RESPIRATORY TRACT INFECTION 388 0.0149
140 CONJUNCTIVAL OEDEMA 15 0.0146
141 VACCINATION FAILURE 24 0.0144
142 SPINAL CORD COMPRESSION 56 0.0144
143 APLASIA 28 0.0143
144 ADENOCARCINOMA OF COLON 26 0.0139
145 HYPOPROTEINAEMIA 26 0.0137
146 SALMONELLOSIS 23 0.0136
147 RHINOVIRUS INFECTION 53 0.0136
148 PERIPHERAL MOTOR NEUROPATHY 19 0.0136
149 BRONCHOPULMONARY ASPERGILLOSIS 105 0.0135
150 CUTANEOUS T-CELL LYMPHOMA 17 0.0135
151 PNEUMONIA VIRAL 43 0.0135
152 ACUTE LYMPHOCYTIC LEUKAEMIA 38 0.0134
153 SINUS NODE DYSFUNCTION 24 0.0131
154 DERMATITIS EXFOLIATIVE GENERALISED 45 0.0129
155 LEUKOENCEPHALOPATHY 48 0.0129
156 MYELODYSPLASTIC SYNDROME 185 0.0128
157 PNEUMONIA STAPHYLOCOCCAL 25 0.0127
158 PNEUMOCYSTIS JIROVECII INFECTION 15 0.0126
159 BRONCHOSPASM 179 0.0125
160 ATRIAL FLUTTER 100 0.0125
161 BLOOD IMMUNOGLOBULIN G INCREASED 15 0.0123
162 TRANSITIONAL CELL CARCINOMA 16 0.0123
163 POTENTIATING DRUG INTERACTION 41 0.0122
164 HEPATITIS B REACTIVATION 38 0.0120
165 BACTERAEMIA 139 0.0117
166 PSEUDOMEMBRANOUS COLITIS 26 0.0116
167 TACHYPNOEA 158 0.0116
168 NORMOCYTIC ANAEMIA 17 0.0116
169 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 27 0.0115
170 SOFT TISSUE INFECTION 21 0.0115
171 PANCYTOPENIA 640 0.0114
172 PNEUMONIA BACTERIAL 105 0.0114
173 NEUTROPENIC SEPSIS 81 0.0113
174 INTENTIONAL PRODUCT USE ISSUE 989 0.0113
175 URINARY TRACT INFECTION BACTERIAL 28 0.0111
176 PNEUMOMEDIASTINUM 20 0.0111
177 LEUKOPENIA 546 0.0109
178 CYSTITIS HAEMORRHAGIC 44 0.0109
179 MENINGITIS CRYPTOCOCCAL 19 0.0109
180 PSEUDOMONAL SEPSIS 19 0.0108
181 HEPATIC CYTOLYSIS 138 0.0108
182 TROPONIN I INCREASED 18 0.0108
183 RESPIRATORY SYNCYTIAL VIRUS INFECTION 94 0.0108
184 ENCEPHALITIS AUTOIMMUNE 14 0.0106
185 LICHENOID KERATOSIS 24 0.0105
186 SEPTIC SHOCK 456 0.0105
187 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 15 0.0104
188 PNEUMONIA FUNGAL 41 0.0104
189 VASCULAR DEVICE INFECTION 47 0.0104
190 PNEUMONIA KLEBSIELLA 19 0.0103
191 VENOUS THROMBOSIS 40 0.0102
192 NEUTROPENIC COLITIS 21 0.0101
193 ESCHERICHIA URINARY TRACT INFECTION 43 0.0101
194 CYTOMEGALOVIRUS COLITIS 23 0.0100
195 SUDDEN HEARING LOSS 20 0.0099
196 SPINAL COLUMN INJURY 22 0.0099
197 ACUTE PULMONARY OEDEMA 55 0.0098
198 THROMBOPHLEBITIS 34 0.0097
199 WHITE BLOOD CELL COUNT DECREASED 1051 0.0097
200 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 92 0.0096
201 RECTAL ABSCESS 16 0.0095
202 PLATELET COUNT DECREASED 1013 0.0095
203 ILEUS PARALYTIC 42 0.0094
204 TEMPERATURE INTOLERANCE 97 0.0094
205 ENDOCARDITIS 48 0.0093
206 APLASIA PURE RED CELL 32 0.0093
207 VARICELLA ZOSTER VIRUS INFECTION 19 0.0092
208 ATYPICAL PNEUMONIA 27 0.0090
209 EXTRAVASATION 37 0.0090
210 FULL BLOOD COUNT DECREASED 179 0.0089
211 HYPOCALCAEMIA 167 0.0088
212 GASTROINTESTINAL TOXICITY 42 0.0087
213 VENOUS THROMBOSIS LIMB 18 0.0087
214 ASPHYXIA 71 0.0087
215 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 51 0.0086
216 ADVERSE REACTION 114 0.0086
217 HAEMOLYSIS 66 0.0085
218 RESPIRATORY SYMPTOM 24 0.0084
219 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 215 0.0083
220 ACUTE MYELOID LEUKAEMIA 129 0.0083
221 UROSEPSIS 76 0.0082
222 ANGLE CLOSURE GLAUCOMA 21 0.0082
223 NEUTROPHIL COUNT ABNORMAL 23 0.0081
224 PARESIS 18 0.0081
225 CARDIAC FAILURE 647 0.0081
226 ANAEMIA 1534 0.0080
227 ERYSIPELAS 40 0.0080
228 EMBOLISM 66 0.0079
229 BONE MARROW DISORDER 24 0.0079
230 HUMERUS FRACTURE 38 0.0079
231 RASH MACULO-PAPULAR 175 0.0079
232 GUILLAIN-BARRE SYNDROME 38 0.0078
233 PNEUMONIA 2511 0.0077
234 ACUTE RESPIRATORY FAILURE 149 0.0077
235 KLEBSIELLA INFECTION 39 0.0077
236 DISEASE PROGRESSION 909 0.0077
237 SEPSIS 854 0.0076
238 CLOSTRIDIUM DIFFICILE COLITIS 81 0.0076
239 MULTIPLE ORGAN DYSFUNCTION SYNDROME 216 0.0076
240 CARDIAC FAILURE ACUTE 50 0.0075
241 CANCER PAIN 19 0.0074
242 COVID-19 1303 0.0074
243 GASTROINTESTINAL INFECTION 66 0.0074
244 HAEMOLYTIC URAEMIC SYNDROME 17 0.0073
245 MUCORMYCOSIS 19 0.0073
246 IMMUNE-MEDIATED MYOSITIS 20 0.0072
247 TOXIC SKIN ERUPTION 73 0.0072
248 ADENOVIRUS INFECTION 21 0.0072
249 LUMBAR VERTEBRAL FRACTURE 33 0.0072
250 STAPHYLOCOCCAL BACTERAEMIA 31 0.0071
251 INFECTION 1029 0.0071
252 WHITE BLOOD CELL DISORDER 19 0.0071
253 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 55 0.0071
254 INFUSION SITE EXTRAVASATION 44 0.0071
255 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 27 0.0071
256 PNEUMONITIS 192 0.0070
257 BONE MARROW FAILURE 143 0.0070
258 PHYSICAL DECONDITIONING 18 0.0070
259 LARYNGEAL OEDEMA 43 0.0070
260 TROPONIN INCREASED 53 0.0070
261 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 52 0.0069
262 STAPHYLOCOCCAL SEPSIS 34 0.0069
263 LABORATORY TEST ABNORMAL 203 0.0069
264 STRESS CARDIOMYOPATHY 40 0.0069
265 ATRIAL FIBRILLATION 662 0.0068
266 THORACIC VERTEBRAL FRACTURE 20 0.0068
267 UPPER RESPIRATORY TRACT INFECTION 310 0.0067
268 LEFT VENTRICULAR FAILURE 23 0.0067
269 HEPATITIS B 40 0.0066
270 HAEMATOLOGICAL INFECTION 16 0.0065
271 OESOPHAGEAL CANDIDIASIS 26 0.0065
272 APLASTIC ANAEMIA 34 0.0065
273 ENCEPHALITIS 45 0.0065
274 ISCHAEMIC STROKE 116 0.0065
275 CHILLS 761 0.0065
276 ARTERIOSPASM CORONARY 26 0.0065
277 HYPERTENSIVE CRISIS 72 0.0065
278 GASTROENTERITIS 94 0.0064
279 EPSTEIN-BARR VIRUS INFECTION 40 0.0064
280 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 17 0.0064
281 CORONAVIRUS INFECTION 42 0.0063
282 COMPRESSION FRACTURE 34 0.0063
283 HYPERURICAEMIA 26 0.0063
284 MIXED LIVER INJURY 19 0.0063
285 ASPERGILLUS INFECTION 41 0.0062
286 GASTRIC PERFORATION 17 0.0062
287 EOSINOPHILIA 109 0.0062
288 HYPOKALAEMIA 286 0.0062
289 TOXIC ENCEPHALOPATHY 31 0.0061
290 ORAL PRURITUS 14 0.0061
291 HEPATITIS FULMINANT 18 0.0061
292 BLOOD DISORDER 48 0.0060
293 PULMONARY TOXICITY 42 0.0059
294 HYPERVOLAEMIA 29 0.0059
295 NOCARDIOSIS 15 0.0059
296 SQUAMOUS CELL CARCINOMA 55 0.0058
297 SPINAL COMPRESSION FRACTURE 48 0.0058
298 DEEP VEIN THROMBOSIS 376 0.0058
299 IMMUNOSUPPRESSION 51 0.0058
300 BASAL CELL CARCINOMA 90 0.0058
301 SUDDEN DEATH 61 0.0058
302 NEOPLASM 66 0.0057
303 NON-CARDIAC CHEST PAIN 18 0.0057
304 LUNG ADENOCARCINOMA 17 0.0056
305 EMBOLISM VENOUS 17 0.0056
306 LYMPHOCYTE COUNT DECREASED 99 0.0056
307 DUODENAL ULCER HAEMORRHAGE 16 0.0056
308 RETINAL VEIN OCCLUSION 16 0.0056
309 HYPOXIA 196 0.0056
310 ILEUS 69 0.0055
311 SPINAL PAIN 65 0.0055
312 NEPHROTIC SYNDROME 38 0.0055
313 ENCEPHALOPATHY 135 0.0055
314 HAEMOLYTIC ANAEMIA 49 0.0055
315 FEMORAL NECK FRACTURE 28 0.0055
316 RESPIRATORY FAILURE 397 0.0054
317 ACUTE CORONARY SYNDROME 45 0.0054
318 HYPOALBUMINAEMIA 42 0.0054
319 ORTHOSTATIC HYPOTENSION 94 0.0054
320 THROMBOTIC THROMBOCYTOPENIC PURPURA 19 0.0054
321 ACUTE RESPIRATORY DISTRESS SYNDROME 95 0.0054
322 HYPERTHERMIA 41 0.0054
323 RESPIRATORY DISTRESS 148 0.0054
324 TRANSFUSION 56 0.0053
325 DRUG TOLERANCE DECREASED 15 0.0053
326 MUSCULOSKELETAL CHEST PAIN 82 0.0053
327 CHOLECYSTITIS ACUTE 30 0.0053
328 VIRAL UPPER RESPIRATORY TRACT INFECTION 25 0.0053
329 AUTOIMMUNE HAEMOLYTIC ANAEMIA 18 0.0052
330 ORGANISING PNEUMONIA 26 0.0052
331 BRAIN NATRIURETIC PEPTIDE INCREASED 16 0.0052
332 DECUBITUS ULCER 42 0.0051
333 PULMONARY EMBOLISM 485 0.0051
334 MALNUTRITION 57 0.0051
335 ANXIETY DISORDER 17 0.0051
336 PYELONEPHRITIS 44 0.0051
337 BACTERIAL INFECTION 94 0.0050
338 ACUTE KIDNEY INJURY 767 0.0050
339 SUDDEN CARDIAC DEATH 17 0.0050
340 PARTIAL SEIZURES 26 0.0050
341 THERAPY NON-RESPONDER 223 0.0050
342 SKIN TOXICITY 28 0.0049
343 MALIGNANT MELANOMA 66 0.0049
344 OXYGEN SATURATION DECREASED 276 0.0049
345 PYREXIA 1699 0.0049
346 NEUROTOXICITY 86 0.0049
347 HYPOPHOSPHATAEMIA 36 0.0049
348 SUSPECTED COVID-19 16 0.0048
349 OSTEONECROSIS OF JAW 120 0.0048
350 OTITIS MEDIA 16 0.0048
351 TASTE DISORDER 98 0.0048
352 LARGE INTESTINE PERFORATION 33 0.0047
353 IRIDOCYCLITIS 15 0.0047
354 CARDIOTOXICITY 42 0.0047
355 AORTIC VALVE INCOMPETENCE 20 0.0047
356 CLAVICLE FRACTURE 18 0.0047
357 INCORRECT DRUG ADMINISTRATION RATE 20 0.0047
358 MENINGITIS ASEPTIC 21 0.0047
359 CUTANEOUS VASCULITIS 17 0.0047
360 MENINGITIS 31 0.0046
361 OFF LABEL USE 4059 0.0046
362 HORDEOLUM 20 0.0046
363 HYPOMAGNESAEMIA 64 0.0046
364 LOWER RESPIRATORY TRACT INFECTION 208 0.0046
365 PRODUCT PREPARATION ISSUE 30 0.0046
366 EJECTION FRACTION DECREASED 71 0.0046
367 CARDIAC DYSFUNCTION 17 0.0046
368 ESCHERICHIA INFECTION 37 0.0045
369 CHOLESTASIS 86 0.0045
370 PSEUDOMONAS INFECTION 38 0.0044
371 OROPHARYNGEAL DISCOMFORT 40 0.0044
372 SUSPECTED OFF LABEL USE 20 0.0044
373 CLOSTRIDIUM DIFFICILE INFECTION 96 0.0044
374 MUCOSAL INFLAMMATION 115 0.0044
375 ARTHRITIS BACTERIAL 18 0.0044
376 IMMUNE THROMBOCYTOPENIA 20 0.0044
377 GENERALISED OEDEMA 54 0.0044
378 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
379 HEPATOCELLULAR INJURY 61 0.0043
380 PULMONARY OEDEMA 192 0.0043
381 INTERSTITIAL LUNG DISEASE 207 0.0043
382 BRONCHIOLITIS 15 0.0043
383 DEAFNESS NEUROSENSORY 14 0.0043
384 PROTEIN TOTAL DECREASED 16 0.0042
385 FACIAL PARALYSIS 36 0.0042
386 BONE PAIN 245 0.0042
387 SARS-COV-2 TEST POSITIVE 55 0.0042
388 PERIPHERAL ISCHAEMIA 17 0.0042
389 IMMUNODEFICIENCY 62 0.0042
390 ENTEROCOLITIS 24 0.0042
391 HICCUPS 34 0.0041
392 CARDIOGENIC SHOCK 59 0.0041
393 HERPES ZOSTER 236 0.0041
394 MYOCARDITIS 47 0.0041
395 INFLUENZA 457 0.0041
396 ORAL INFECTION 16 0.0041
397 RHINITIS 33 0.0041
398 AGRANULOCYTOSIS 76 0.0041
399 BENIGN PROSTATIC HYPERPLASIA 21 0.0041
400 BLOOD CREATININE ABNORMAL 14 0.0040
401 FAILURE TO THRIVE 21 0.0040
402 PLEURISY 24 0.0040
403 HYPOPNOEA 14 0.0040
404 BRONCHITIS 298 0.0040
405 RED BLOOD CELL COUNT DECREASED 115 0.0040
406 AORTIC STENOSIS 14 0.0040
407 JAUNDICE CHOLESTATIC 14 0.0040
408 PLEURAL EFFUSION 241 0.0040
409 RENAL IMPAIRMENT 332 0.0039
410 SINUS TACHYCARDIA 56 0.0039
411 DIVERTICULITIS 109 0.0039
412 DRUG INTOLERANCE 378 0.0039
413 ARTHRITIS INFECTIVE 18 0.0039
414 PERFORMANCE STATUS DECREASED 18 0.0039
415 THROMBOSIS 310 0.0038
416 HYPERGLYCAEMIA 140 0.0038
417 INFLAMMATORY MARKER INCREASED 19 0.0038
418 BLOOD CALCIUM DECREASED 43 0.0038
419 CONSTIPATION 833 0.0038
420 HEPATOTOXICITY 84 0.0038
421 HYPOVOLAEMIC SHOCK 18 0.0038
422 CARDIAC FAILURE CHRONIC 16 0.0038
423 CHRONIC SINUSITIS 14 0.0037
424 CHEST DISCOMFORT 380 0.0037
425 MITRAL VALVE INCOMPETENCE 42 0.0037
426 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 262 0.0037
427 APPENDICITIS 34 0.0036
428 HAEMOGLOBIN DECREASED 372 0.0036
429 RENAL FAILURE 479 0.0036
430 RIB FRACTURE 74 0.0036
431 BLOOD LACTATE DEHYDROGENASE INCREASED 57 0.0036
432 ENTERITIS 23 0.0036
433 HYPERTRIGLYCERIDAEMIA 21 0.0036
434 COLITIS ISCHAEMIC 24 0.0036
435 COLITIS 134 0.0035
436 PRODUCT TEMPERATURE EXCURSION ISSUE 18 0.0035
437 NEUROLOGICAL SYMPTOM 20 0.0035
438 PRESYNCOPE 85 0.0035
439 LUNG DISORDER 171 0.0035
440 HAEMORRHOIDAL HAEMORRHAGE 17 0.0035
441 INTERCEPTED MEDICATION ERROR 16 0.0034
442 CELLULITIS 174 0.0034
443 ADVERSE EVENT 318 0.0034
444 DRUG ERUPTION 61 0.0034
445 FRACTURE 65 0.0034
446 SYNCOPE 342 0.0034
447 DISSEMINATED INTRAVASCULAR COAGULATION 48 0.0034
448 SPINAL FRACTURE 68 0.0034
449 DEVICE RELATED INFECTION 52 0.0034
450 VENTRICULAR EXTRASYSTOLES 35 0.0034
451 SECOND PRIMARY MALIGNANCY 28 0.0034
452 CHOLECYSTITIS 40 0.0034
453 DIARRHOEA 2161 0.0033
454 ACUTE MYOCARDIAL INFARCTION 98 0.0033
455 PRODUCT PREPARATION ERROR 68 0.0033
456 URINARY TRACT INFECTION 564 0.0033
457 IMMUNE SYSTEM DISORDER 43 0.0033
458 DECREASED IMMUNE RESPONSIVENESS 32 0.0033
459 TONSILLITIS 17 0.0033
460 DELIRIUM 113 0.0033
461 BRAIN FOG 51 0.0033
462 CHOLANGITIS 20 0.0032
463 MONOPLEGIA 14 0.0032
464 PULMONARY HAEMORRHAGE 25 0.0032
465 BLOOD CALCIUM INCREASED 28 0.0032
466 ANAPHYLACTIC REACTION 176 0.0032
467 ELECTROLYTE IMBALANCE 37 0.0032
468 CARDIOMYOPATHY 47 0.0032
469 PARKINSONISM 31 0.0032
470 SKIN ABRASION 15 0.0032
471 SNEEZING 71 0.0032
472 HEPATITIS CHOLESTATIC 19 0.0032
473 GINGIVITIS 17 0.0031
474 TRANSAMINASES INCREASED 70 0.0031
475 TRICUSPID VALVE INCOMPETENCE 25 0.0031
476 BLOOD CREATININE INCREASED 205 0.0031
477 BONE DISORDER 57 0.0031
478 SKIN INFECTION 35 0.0031
479 SENSITIVE SKIN 23 0.0031
480 GENERAL PHYSICAL HEALTH DETERIORATION 360 0.0031
481 RESPIRATORY DISORDER 93 0.0031
482 ENTEROCOCCAL INFECTION 15 0.0031
483 HEPATIC FUNCTION ABNORMAL 115 0.0031
484 THROAT IRRITATION 138 0.0031
485 OEDEMA 164 0.0030
486 HAEMODYNAMIC INSTABILITY 23 0.0030
487 GOUT 54 0.0030
488 BLOOD TEST ABNORMAL 42 0.0030
489 RHINORRHOEA 193 0.0030
490 ANAL ABSCESS 16 0.0030
491 DIALYSIS 42 0.0030
492 INGUINAL HERNIA 18 0.0030
493 MENTAL STATUS CHANGES 82 0.0029
494 INTESTINAL PERFORATION 33 0.0029
495 FULL BLOOD COUNT ABNORMAL 31 0.0029
496 PHLEBITIS 15 0.0029
497 TACHYCARDIA 260 0.0029
498 PNEUMONIA ASPIRATION 73 0.0029
499 NEURALGIA 71 0.0029
500 VIRAL INFECTION 97 0.0029
501 COUGH 815 0.0029
502 DYSPNOEA 1644 0.0029
503 HYPERBILIRUBINAEMIA 30 0.0029
504 STREPTOCOCCAL INFECTION 16 0.0029
505 BACK PAIN 666 0.0029
506 PULMONARY ALVEOLAR HAEMORRHAGE 16 0.0028
507 PANCREATITIS ACUTE 64 0.0028
508 PELVIC FRACTURE 22 0.0028
509 NASAL CONGESTION 166 0.0028
510 RESPIRATORY RATE INCREASED 25 0.0028
511 PERICARDIAL EFFUSION 65 0.0028
512 NERVOUS SYSTEM DISORDER 87 0.0028
513 CORONARY ARTERY STENOSIS 14 0.0028
514 GRAFT VERSUS HOST DISEASE 20 0.0028
515 WHEEZING 163 0.0027
516 LIVER FUNCTION TEST INCREASED 59 0.0027
517 FATIGUE 2138 0.0027
518 HAEMORRHAGE INTRACRANIAL 41 0.0027
519 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 47 0.0027
520 OLIGURIA 17 0.0027
521 ORAL CANDIDIASIS 36 0.0027
522 HYPERTRANSAMINASAEMIA 19 0.0027
523 C-REACTIVE PROTEIN INCREASED 99 0.0027
524 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
525 DRUG RESISTANCE 69 0.0027
526 AGEUSIA 67 0.0027
527 HYPERTENSION 566 0.0027
528 FLANK PAIN 25 0.0027
529 RASH 1160 0.0027
530 OEDEMA PERIPHERAL 324 0.0027
531 CARDIO-RESPIRATORY ARREST 111 0.0027
532 SPLENOMEGALY 31 0.0026
533 PULMONARY ARTERIAL HYPERTENSION 38 0.0026
534 PRODUCT USE ISSUE 490 0.0026
535 THERAPEUTIC RESPONSE DECREASED 158 0.0026
536 HERPES VIRUS INFECTION 15 0.0026
537 GENERALISED TONIC-CLONIC SEIZURE 43 0.0026
538 DIFFUSE LARGE B-CELL LYMPHOMA 20 0.0026
539 MOUTH HAEMORRHAGE 19 0.0026
540 PHARYNGITIS 32 0.0026
541 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 141 0.0026
542 PULMONARY THROMBOSIS 28 0.0026
543 FAECALOMA 14 0.0026
544 GASTROINTESTINAL INFLAMMATION 20 0.0026
545 THROAT TIGHTNESS 69 0.0025
546 COGNITIVE DISORDER 119 0.0025
547 MYOCARDIAL ISCHAEMIA 29 0.0025
548 LEUKAEMIA 24 0.0025
549 ADVERSE DRUG REACTION 227 0.0025
550 ANAPHYLACTIC SHOCK 65 0.0025
551 TRANSIENT ISCHAEMIC ATTACK 85 0.0025
552 CEREBRAL INFARCTION 61 0.0025
553 SINUS BRADYCARDIA 24 0.0025
554 CYANOSIS 39 0.0025
555 PRODUCT DISTRIBUTION ISSUE 23 0.0025
556 SHOCK 57 0.0025
557 PROTEINURIA 47 0.0025
558 HYPONATRAEMIA 139 0.0025
559 PRODUCT USE IN UNAPPROVED INDICATION 611 0.0025
560 NEPHROPATHY 23 0.0025
561 BLOOD POTASSIUM DECREASED 74 0.0025
562 CATARACT 146 0.0024
563 HYPOTENSION 491 0.0024
564 ASTHENIA 919 0.0024
565 LOWER GASTROINTESTINAL HAEMORRHAGE 18 0.0024
566 RIGHT VENTRICULAR FAILURE 17 0.0024
567 ADRENAL INSUFFICIENCY 29 0.0024
568 TOOTH DISORDER 53 0.0024
569 LUNG INFECTION 37 0.0024
570 MUSCLE SPASMS 437 0.0024
571 ATELECTASIS 23 0.0024
572 PRODUCTIVE COUGH 113 0.0024
573 GENERAL PHYSICAL CONDITION ABNORMAL 16 0.0024
574 ARRHYTHMIA 111 0.0023
575 RENAL DISORDER 109 0.0023
576 GLAUCOMA 45 0.0023
577 PRODUCT CONTAINER ISSUE 20 0.0023
578 DECREASED APPETITE 540 0.0023
579 FEMUR FRACTURE 72 0.0023
580 BLOOD MAGNESIUM DECREASED 20 0.0023
581 PLATELET COUNT ABNORMAL 14 0.0023
582 PULMONARY HYPERTENSION 48 0.0023
583 END STAGE RENAL DISEASE 42 0.0023
584 SINUS CONGESTION 31 0.0023
585 RASH PRURITIC 123 0.0023
586 BLOOD BILIRUBIN INCREASED 61 0.0023
587 HEPATOMEGALY 22 0.0022
588 SPINAL DISORDER 21 0.0022
589 ASCITES 65 0.0022
590 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 115 0.0022
591 RESPIRATORY TRACT CONGESTION 35 0.0022
592 SKIN REACTION 31 0.0022
593 MYOPATHY 19 0.0022
594 PULMONARY FIBROSIS 42 0.0022
595 VENTRICULAR TACHYCARDIA 36 0.0022
596 URINE OUTPUT DECREASED 19 0.0022
597 ALTERED STATE OF CONSCIOUSNESS 47 0.0022
598 SUBDURAL HAEMATOMA 31 0.0022
599 ANGINA UNSTABLE 14 0.0022
600 HERPES SIMPLEX 14 0.0022
601 MASS 30 0.0021
602 PHARYNGEAL SWELLING 21 0.0021
603 VASCULITIS 25 0.0021
604 EPISTAXIS 160 0.0021
605 THERAPY CHANGE 21 0.0021
606 CANDIDA INFECTION 36 0.0021
607 THERAPY INTERRUPTED 152 0.0021
608 PULMONARY CONGESTION 28 0.0021
609 GLOMERULAR FILTRATION RATE DECREASED 26 0.0021
610 TREMOR 348 0.0021
611 GASTROINTESTINAL DISORDER 186 0.0021
612 DYSPHONIA 121 0.0021
613 SKIN DISORDER 69 0.0021
614 BRADYCARDIA 107 0.0020
615 PETECHIAE 21 0.0020
616 TRANSPLANT REJECTION 16 0.0020
617 HEPATIC FAILURE 60 0.0020
618 ANGINA PECTORIS 57 0.0020
619 DEATH 1713 0.0020
620 OSTEOMYELITIS 36 0.0020
621 BLOOD COUNT ABNORMAL 30 0.0020
622 NERVE INJURY 22 0.0020
623 CARDIAC ARREST 163 0.0020
624 TOOTH INFECTION 26 0.0020
625 HOSPITALISATION 303 0.0020
626 NEPHROPATHY TOXIC 22 0.0020
627 CARDIAC DISORDER 183 0.0020
628 COLON CANCER 29 0.0019
629 INJECTION SITE EXTRAVASATION 24 0.0019
630 TREATMENT NONCOMPLIANCE 106 0.0019
631 DEMENTIA 54 0.0019
632 PERITONITIS 40 0.0019
633 DEHYDRATION 257 0.0019
634 HOSPICE CARE 19 0.0019
635 HEPATIC CIRRHOSIS 36 0.0019
636 LIVER INJURY 47 0.0019
637 ELECTROCARDIOGRAM ABNORMAL 15 0.0019
638 NEOPLASM PROGRESSION 66 0.0019
639 BLOOD PRESSURE DECREASED 126 0.0019
640 PRODUCT DOSE OMISSION ISSUE 555 0.0019
641 PRODUCT ADMINISTRATION ERROR 38 0.0019
642 CIRCULATORY COLLAPSE 32 0.0019
643 EPILEPSY 57 0.0019
644 ANURIA 16 0.0019
645 LACRIMATION INCREASED 56 0.0019
646 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
647 RETINAL DETACHMENT 17 0.0018
648 SHOCK HAEMORRHAGIC 15 0.0018
649 ALANINE AMINOTRANSFERASE INCREASED 113 0.0018
650 SEASONAL ALLERGY 26 0.0018
651 POLYURIA 15 0.0018
652 NIGHT SWEATS 59 0.0018
653 PERIPHERAL SWELLING 281 0.0018
654 MALIGNANT NEOPLASM PROGRESSION 186 0.0018
655 HAEMATOMA 47 0.0018
656 DYSPNOEA EXERTIONAL 68 0.0018
657 NAUSEA 1419 0.0018
658 PRODUCT PACKAGING ISSUE 17 0.0018
659 CEREBRAL HAEMORRHAGE 64 0.0018
660 SMALL INTESTINAL OBSTRUCTION 22 0.0018
661 BLOOD ALKALINE PHOSPHATASE INCREASED 44 0.0018
662 SKIN LACERATION 19 0.0017
663 PRODUCT PRESCRIBING ISSUE 38 0.0017
664 BRAIN OEDEMA 22 0.0017
665 HYPERKALAEMIA 61 0.0017
666 IRON DEFICIENCY ANAEMIA 16 0.0017
667 CONFUSIONAL STATE 280 0.0017
668 UPPER GASTROINTESTINAL HAEMORRHAGE 29 0.0017
669 VOMITING 803 0.0017
670 SPINAL OSTEOARTHRITIS 15 0.0017
671 TUBULOINTERSTITIAL NEPHRITIS 32 0.0017
672 SKIN ULCER 44 0.0017
673 NASOPHARYNGITIS 313 0.0017
674 SINUSITIS 173 0.0017
675 ATAXIA 20 0.0017
676 ASPARTATE AMINOTRANSFERASE INCREASED 89 0.0017
677 CONJUNCTIVITIS 31 0.0017
678 SUBARACHNOID HAEMORRHAGE 17 0.0017
679 CHEST PAIN 309 0.0017
680 CARDIAC FAILURE CONGESTIVE 134 0.0017
681 STOMATITIS 101 0.0017
682 CYSTITIS 53 0.0017
683 FACE OEDEMA 28 0.0017
684 HYPERSENSITIVITY 308 0.0017
685 LOCALISED INFECTION 40 0.0017
686 GASTRIC HAEMORRHAGE 19 0.0016
687 FLUID OVERLOAD 24 0.0016
688 WOUND INFECTION 18 0.0016
689 HAEMATURIA 56 0.0016
690 UVEITIS 22 0.0016
691 HYPOAESTHESIA 242 0.0016
692 ACUTE HEPATIC FAILURE 22 0.0016
693 STAPHYLOCOCCAL INFECTION 53 0.0016
694 FLUSHING 163 0.0016
695 LEUKOCYTOSIS 29 0.0016
696 NAIL DISORDER 14 0.0016
697 DISEASE RECURRENCE 76 0.0016
698 DEPRESSED LEVEL OF CONSCIOUSNESS 63 0.0016
699 LUNG INFILTRATION 14 0.0016
700 FEELING COLD 44 0.0016
701 TOOTH ABSCESS 16 0.0016
702 SCIATICA 25 0.0016
703 SINUS DISORDER 31 0.0016
704 DRUG-INDUCED LIVER INJURY 49 0.0016
705 JAUNDICE 42 0.0016
706 URINARY RETENTION 52 0.0016
707 FLUID RETENTION 79 0.0016
708 HERNIA 30 0.0015
709 DIZZINESS POSTURAL 15 0.0015
710 OROPHARYNGEAL PAIN 143 0.0015
711 BLOOD POTASSIUM INCREASED 25 0.0015
712 UNEVALUABLE EVENT 116 0.0015
713 COLD SWEAT 27 0.0015
714 LIVER DISORDER 67 0.0015
715 DERMATITIS ALLERGIC 19 0.0015
716 INSOMNIA 402 0.0015
717 MUSCLE ATROPHY 19 0.0015
718 WEIGHT DECREASED 418 0.0015
719 BODY HEIGHT DECREASED 16 0.0015
720 HEPATIC ENZYME INCREASED 102 0.0015
721 BLOOD PRESSURE INCREASED 228 0.0015
722 PARAESTHESIA 234 0.0015
723 BODY TEMPERATURE INCREASED 30 0.0015
724 EYELID OEDEMA 17 0.0015
725 HAEMATOCRIT DECREASED 29 0.0015
726 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
727 INTESTINAL OBSTRUCTION 55 0.0015
728 SKIN LESION 40 0.0015
729 UPPER LIMB FRACTURE 29 0.0015
730 AUTOIMMUNE DISORDER 14 0.0014
731 HAEMOPTYSIS 40 0.0014
732 HIP FRACTURE 46 0.0014
733 HYPERLIPIDAEMIA 17 0.0014
734 BACK DISORDER 23 0.0014
735 THERAPEUTIC PRODUCT EFFECT DECREASED 63 0.0014
736 ILLNESS 143 0.0014
737 CORONARY ARTERY DISEASE 42 0.0014
738 DERMATITIS 29 0.0014
739 FALL 460 0.0014
740 TOOTHACHE 25 0.0014
741 COAGULOPATHY 23 0.0014
742 LIVER FUNCTION TEST ABNORMAL 40 0.0014
743 HYPERHIDROSIS 177 0.0014
744 OSTEONECROSIS 45 0.0014
745 HEMIPARESIS 23 0.0014
746 DRUG INEFFECTIVE 1786 0.0014
747 OCULAR HYPERAEMIA 64 0.0013
748 HYPOPHAGIA 34 0.0013
749 GASTROENTERITIS VIRAL 24 0.0013
750 HEPATITIS 34 0.0013
751 EYE INFECTION 15 0.0013
752 HYPOAESTHESIA ORAL 20 0.0013
753 BLINDNESS 54 0.0013
754 RESTLESS LEGS SYNDROME 24 0.0013
755 DYSGEUSIA 98 0.0013
756 EYE SWELLING 49 0.0013
757 INTERNAL HAEMORRHAGE 15 0.0013
758 ABDOMINAL PAIN 305 0.0013
759 VISION BLURRED 180 0.0013
760 PROSTATIC SPECIFIC ANTIGEN INCREASED 18 0.0013
761 PAIN IN JAW 37 0.0013
762 PANCREATITIS 69 0.0013
763 DYSURIA 48 0.0013
764 GASTRITIS 34 0.0013
765 LETHARGY 74 0.0013
766 PRURITUS 494 0.0013
767 LOSS OF CONSCIOUSNESS 163 0.0013
768 PHOTOSENSITIVITY REACTION 21 0.0013
769 DIPLOPIA 33 0.0013
770 TREATMENT FAILURE 105 0.0013
771 INFLUENZA LIKE ILLNESS 104 0.0013
772 CARDIOVASCULAR DISORDER 32 0.0013
773 DIABETES MELLITUS 96 0.0013
774 APHASIA 38 0.0013
775 HYPERSOMNIA 36 0.0013
776 SKIN CANCER 27 0.0013
777 INFUSION SITE PAIN 16 0.0012
778 GALLBLADDER DISORDER 22 0.0012
779 HEART RATE INCREASED 122 0.0012
780 DIZZINESS 613 0.0012
781 BALANCE DISORDER 106 0.0012
782 WHITE BLOOD CELL COUNT INCREASED 47 0.0012
783 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
784 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 220 0.0012
785 DYSPEPSIA 120 0.0012
786 APHONIA 17 0.0012
787 LYMPHADENOPATHY 43 0.0012
788 BLOOD PRESSURE ABNORMAL 24 0.0012
789 FEELING JITTERY 23 0.0012
790 ORAL PAIN 27 0.0012
791 MALAISE 528 0.0012
792 FUNGAL INFECTION 40 0.0012
793 DEAFNESS 31 0.0012
794 SENSORY DISTURBANCE 19 0.0012
795 PRODUCT DOSE OMISSION 77 0.0012
796 PARAESTHESIA ORAL 17 0.0012
797 GINGIVAL BLEEDING 16 0.0012
798 METASTASES TO CENTRAL NERVOUS SYSTEM 15 0.0012
799 METASTASES TO BONE 19 0.0012
800 DISTURBANCE IN ATTENTION 62 0.0011
801 DISCOMFORT 70 0.0011
802 SKIN HAEMORRHAGE 17 0.0011
803 NECK PAIN 64 0.0011
804 PULMONARY MASS 17 0.0011
805 INTERCEPTED PRODUCT PREPARATION ERROR 14 0.0011
806 THERAPEUTIC RESPONSE UNEXPECTED 51 0.0011
807 MELAENA 25 0.0011
808 ERYTHEMA 232 0.0011
809 SLEEP DISORDER 79 0.0011
810 VISUAL ACUITY REDUCED 37 0.0011
811 DISORIENTATION 44 0.0011
812 CHRONIC KIDNEY DISEASE 84 0.0011
813 ANOSMIA 16 0.0011
814 GASTROINTESTINAL HAEMORRHAGE 92 0.0011
815 LYMPHOMA 17 0.0011
816 MUSCULAR WEAKNESS 125 0.0011
817 EAR INFECTION 29 0.0011
818 TOXICITY TO VARIOUS AGENTS 183 0.0011
819 GAIT INABILITY 36 0.0011
820 HAEMORRHOIDS 21 0.0011
821 BLOOD UREA INCREASED 18 0.0011
822 ABDOMINAL DISTENSION 112 0.0011
823 RASH ERYTHEMATOUS 51 0.0011
824 LIMB DISCOMFORT 33 0.0011
825 ABSCESS 17 0.0011
826 BEDRIDDEN 14 0.0011
827 POLLAKIURIA 44 0.0011
828 URTICARIA 176 0.0010
829 EYE PRURITUS 35 0.0010
830 CEREBROVASCULAR ACCIDENT 176 0.0010
831 PAIN 635 0.0010
832 CONTUSION 99 0.0010
833 HEART RATE DECREASED 36 0.0010
834 LUNG NEOPLASM MALIGNANT 42 0.0010
835 CENTRAL NERVOUS SYSTEM LESION 14 0.0010
836 GASTROOESOPHAGEAL REFLUX DISEASE 82 0.0010
837 VERTIGO 62 0.0010
838 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
839 HEAD INJURY 32 0.0010
840 PRODUCT PRESCRIBING ERROR 24 0.0010
841 HYPOACUSIS 43 0.0010
842 PAIN IN EXTREMITY 292 0.0010
843 ABDOMINAL DISCOMFORT 166 0.0010
844 EATING DISORDER 21 0.0010
845 DRUG DOSE OMISSION 163 0.0010
846 RETCHING 21 0.0010
847 VISUAL IMPAIRMENT 122 0.0010
848 URINARY INCONTINENCE 29 0.0010
849 SEIZURE 113 0.0010
850 PARALYSIS 14 0.0010
851 EAR PAIN 19 0.0010
852 INJECTION SITE REACTION 67 0.0010
853 UNRESPONSIVE TO STIMULI 25 0.0010
854 PHOTOPHOBIA 18 0.0010
855 PERICARDITIS 16 0.0010
856 CONDITION AGGRAVATED 288 0.0009
857 INTENTIONAL DOSE OMISSION 27 0.0009
858 EYE DISORDER 31 0.0009
859 PALPITATIONS 110 0.0009
860 ABDOMINAL PAIN UPPER 193 0.0009
861 SWELLING FACE 61 0.0009
862 SKIN DISCOLOURATION 43 0.0009
863 MYALGIA 159 0.0009
864 DYSPHAGIA 88 0.0009
865 TINNITUS 42 0.0009
866 PHARYNGEAL OEDEMA 14 0.0009
867 MYOCARDIAL INFARCTION 158 0.0009
868 MUSCULOSKELETAL DISCOMFORT 15 0.0009
869 CHOKING 17 0.0009
870 FEELING ABNORMAL 208 0.0009
871 MUSCLE TIGHTNESS 14 0.0009
872 MUSCULOSKELETAL PAIN 45 0.0009
873 NEOPLASM MALIGNANT 57 0.0009
874 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 41 0.0009
875 MENTAL DISORDER 37 0.0008
876 BLOOD SODIUM DECREASED 16 0.0008
877 SWELLING 79 0.0008
878 MUSCULOSKELETAL DISORDER 16 0.0008
879 FEEDING DISORDER 17 0.0008
880 DRY MOUTH 68 0.0008
881 INCREASED APPETITE 16 0.0008
882 ARTHRALGIA 348 0.0008
883 RESPIRATORY ARREST 23 0.0008
884 BLOOD PRESSURE FLUCTUATION 20 0.0008
885 SKIN EXFOLIATION 70 0.0008
886 RASH MACULAR 29 0.0008
887 MEDICATION ERROR 46 0.0008
888 OSTEOARTHRITIS 35 0.0008
889 SOMNOLENCE 166 0.0008
890 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
891 UNDERDOSE 60 0.0008
892 JOINT SWELLING 99 0.0008
893 THERAPY CESSATION 42 0.0008
894 PAIN OF SKIN 22 0.0008
895 RECTAL HAEMORRHAGE 35 0.0008
896 MEMORY IMPAIRMENT 111 0.0008
897 ASTHMA 91 0.0008
898 METASTASES TO LIVER 14 0.0008
899 INFLAMMATION 41 0.0008
900 GAIT DISTURBANCE 152 0.0008
901 POOR QUALITY SLEEP 17 0.0008
902 ARTHRITIS 61 0.0008
903 LIMB INJURY 21 0.0008
904 PALLOR 21 0.0008
905 DYSARTHRIA 29 0.0008
906 HEADACHE 480 0.0008
907 STEVENS-JOHNSON SYNDROME 17 0.0008
908 PANCREATIC CARCINOMA 22 0.0008
909 WEIGHT INCREASED 170 0.0008
910 ARTHROPATHY 42 0.0008
911 HEART RATE IRREGULAR 17 0.0008
912 IRRITABLE BOWEL SYNDROME 16 0.0007
913 DRUG EFFECT INCOMPLETE 27 0.0007
914 HAEMATOCHEZIA 41 0.0007
915 FOOT FRACTURE 14 0.0007
916 HAEMORRHAGE 76 0.0007
917 FEELING HOT 44 0.0007
918 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 21 0.0007
919 DRY SKIN 95 0.0007
920 CHOLELITHIASIS 23 0.0007
921 BURNING SENSATION 49 0.0007
922 PROSTATE CANCER 56 0.0007
923 AGITATION 51 0.0007
924 CONTRAINDICATED PRODUCT ADMINISTERED 21 0.0007
925 METABOLIC ACIDOSIS 22 0.0007
926 INJECTION SITE RASH 21 0.0007
927 GASTRIC DISORDER 23 0.0007
928 DRY EYE 33 0.0007
929 MENTAL IMPAIRMENT 16 0.0007
930 RESTLESSNESS 24 0.0007
931 ANGIOEDEMA 29 0.0007
932 MUSCLE TWITCHING 15 0.0007
933 LACTIC ACIDOSIS 21 0.0006
934 SURGERY 38 0.0006
935 BLOOD GLUCOSE INCREASED 122 0.0006
936 INCORRECT PRODUCT ADMINISTRATION DURATION 14 0.0006
937 AMNESIA 42 0.0006
938 WOUND 18 0.0006
939 FLATULENCE 36 0.0006
940 NEPHROLITHIASIS 29 0.0006
941 SPEECH DISORDER 33 0.0006
942 TYPE 2 DIABETES MELLITUS 21 0.0006
943 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 44 0.0006
944 MOBILITY DECREASED 44 0.0006
945 EYE PAIN 34 0.0006
946 HYPOTHYROIDISM 19 0.0006
947 GASTRIC CANCER 15 0.0006
948 HAEMATEMESIS 15 0.0006
949 DIABETIC KETOACIDOSIS 14 0.0006
950 NERVOUSNESS 30 0.0006
951 AGGRESSION 28 0.0006
952 OSTEOPOROSIS 23 0.0006
953 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 112 0.0006
954 BLISTER 31 0.0006
955 DYSSTASIA 16 0.0005
956 COMA 26 0.0005
957 ERECTILE DYSFUNCTION 14 0.0005
958 RENAL INJURY 16 0.0005
959 HOT FLUSH 40 0.0005
960 ROAD TRAFFIC ACCIDENT 22 0.0005
961 ALOPECIA 102 0.0005
962 SWOLLEN TONGUE 16 0.0005
963 EYE IRRITATION 29 0.0005
964 RHABDOMYOLYSIS 21 0.0005
965 ANXIETY 142 0.0005
966 DEPRESSION 112 0.0005
967 INJECTION SITE ERYTHEMA 59 0.0005
968 HYPOGLYCAEMIA 23 0.0005
969 DEPRESSED MOOD 25 0.0005
970 BREAST CANCER 43 0.0005
971 IMPAIRED HEALING 15 0.0005
972 MUSCULOSKELETAL STIFFNESS 40 0.0005
973 BLOOD CHOLESTEROL INCREASED 21 0.0005
974 ECZEMA 23 0.0004
975 NO ADVERSE EVENT 76 0.0004
976 DYSKINESIA 17 0.0004
977 PRODUCT STORAGE ERROR 36 0.0004
978 DRUG INTERACTION 64 0.0004
979 HALLUCINATION 29 0.0004
980 IRRITABILITY 23 0.0004
981 INCORRECT DOSE ADMINISTERED 84 0.0004
982 BLOOD GLUCOSE DECREASED 14 0.0003
983 INJURY 20 0.0003
984 ACCIDENTAL EXPOSURE TO PRODUCT 29 0.0003
985 ILL-DEFINED DISORDER 17 0.0003
986 MIGRAINE 26 0.0003
987 INJECTION SITE BRUISING 21 0.0003
988 DRUG EFFECT DECREASED 14 0.0003
989 ACNE 19 0.0003
990 PRODUCT QUALITY ISSUE 31 0.0002
991 PSORIASIS 25 0.0002
992 INJECTION SITE PAIN 58 0.0002
993 OVERDOSE 33 0.0002